Urticaria and Angioedema
| 46. | Maurer, M., Metz, M., and Zuberbier, T.: Urticaria and Angioedema. In: Lebwohl, M., Heymann, W., Coulson, I., and Murrell, D. editors: Treatment of skin disease. 6th ed., London: Elsevier, 2022 |
bc.46
angioedema
Management of chronic urticaria and angioedema
| 39. | Maurer, M.: Management of chronic urticaria and angioedema. In: Agache, I., Brockow, K., and Mortz, C., editors: Global atlas of skin allergy. EAACI, 2019 |
bc.39
The road to better urticaria and angioedema management
| 170. | Riedl, M. and Maurer, M.+: The road to better urticaria and angioedema management. J. Allergy Clin. Immunol. Pract. 2021: 9; 2243-2244. IF: 11.02 |
r.170
Differences and similarities in the mechanisms and clinical expression of bradykinin-mediated vs. mast cell-mediated angioedema
|
169. |
Maurer, M.+, Khan, D. A., Komi, D. E. A., and Kaplan, A. P.: Biologics for the use in chronic spontaneous urticaria: when and which? J. Allergy Clin. Immunol. Pract. 2021: 9; 1067-1078. IF: 11.02 |
r.169
Case Report: Omalizumab for chronic spontaneous urticaria in pregnancy
| 417. | Liao, S. L., Yu, M., Zhao, Z.*, and Maurer, M.+*: Case Report: Omalizumab for chronic spontaneous urticaria in pregnancy. Front. Immunol. 2021: 12; 652973. IF: 8.79 |
o.417
Use of biologics in chronic spontaneous urticaria – beyond omalizumab therapy?
| 168. | Metz, M.+ and Maurer, M.: Use of biologics in chronic spontaneous urticaria – beyond omalizumab therapy? Allergol. Select. 2021: 5; 89-95. IF: N/A |
r.168
Articular angioedema in patients with chronic spontaneous urticaria is frequently misdiagnosed as arthritis
| 405. | Toubi, E., Giménez-Arnau, A. M., Maurer, M., and Vadasz, Z.+: Articular angioedema in patients with chronic spontaneous urticaria is frequently misdiagnosed as arthritis. J. Allergy Clin. Immunol. Pract. 2020: 8; 3232-3233. IF: 8.86 |
o.405
Chronic urticaria treatment patterns and changes in quality of life: AWARE study 2-year results
| 401. | Maurer, M.+, Giménez-Arnau, A., Ensina, L. F., Chu, C.-Y., Jaumont, X, and Tassinari, P.: Chronic urticaria treatment patterns and changes in quality of life: AWARE study 2-year results. World Allergy Organ. J. 2020: 13; 100460. IF: 4.08 |
o.401
Antihistamine-resistant chronic spontaneous urticaria remains undertreated: 2-year data from the AWARE study
| 400. | Maurer, M.+, Costa, C., Giménez-Arnau, A., Guillet, G., Labrador-Horrillo, M., Lapeere, H., Meshkova, R., Savic, S., and Chapman-Rothe, N.: Antihistamine-resistant chronic spontaneous urticaria remains undertreated: 2-year data from the AWARE study. Clin. Exp. Allergy 2020: 50; 1166-1175 IF: 5.02 |
o.400
Validation of the angioedema control test (AECT) – a patient reported outcome instrument for assessing angioedema control
| 388. | Weller, K.+, Donoso, T., Magerl, M., Aygören-Pürsün, E., Staubach, P., Martinez-Saguer, I., Hawro, T., Altrichter, S., Krause, K., Siebenhaar, F., Metz, M., Zuberbier, T., Freier, D., and Maurer, M.: Validation of the angioedema control test (AECT) – a patient reported outcome instrument for assessing angioedema control. J. Allergy Clin. Immunol. Pract. 2020: 8; 2050-2057. IF: 8.86 |
o.388